
A new nasal vaccine being developed by Australian scientists could provide long-term protection from the deadly bacteria Strep A.
The jab, developed by scientists at Griffin University, is currently being tested in Phase I clinical trials.

A new nasal vaccine being developed by Australian scientists could provide long-term protection from the deadly bacteria Strep A.
The jab, developed by scientists at Griffin University, is currently being tested in Phase I clinical trials.